WSA 2009 - BIT Life Sciences' 2nd Annual World Summit of Antivirals 2009 (WSA2009)

Website http://www.bitlifesciences.com/wsa2009/ | Edit Freely

Category WSA 2009

Deadline: May 31, 2009 | Date: July 18, 2009

Venue/Country: Beijing, China

Updated: 2010-06-04 19:32:22 (GMT+9)

Call For Papers - CFP

(High appreciate that you can announcement the summit news on your web site first)

BIT Life Sciences' 2nd Annual World Summit of Antivirals 2009

Theme: Meeting the Health Challenges in the Globalization

Time: July 18-20, 2009

Place: Beijing, China

Website: http://www.bitlifesciences.com/wsa2009

BIT Life Sciences' World Summit Antivirals (WSA) is a focused event for updating the current advances in worldwide R & D of Novel Antiviral Therapeutics. The anticipated attendees will represent top-level decision makers from leading biotech, pharmaceutical and healthcare organizations. WSA is preparing to meet the demands on expert views; up-to-the-minute industry intelligences; professional presentations and poster sessions. WSA also provides an ideal forum for the promotion of relevant companies, products, technologies and services.

Highlights of BIT Life Sciences' 2nd Annual World Summit of Antivirals 2009:

Invite 20-30 high profile speakers from distinguished companies leading the antivirals trend

Offer 150-200 parallel presentations and discussions update current novel R & D status

Arrange 80 scientific and technological posters to share the new findings and breakthroughs

Invite 30-50 exhibitors to demonstrate their product and technology development

Provide 5-10 Showcases for most promising and fast growing companies in antiviral R & D

Schedule 1 to 1 network meeting for your business and collaboration demands.

The topics include:

Track 1: Basic Sciences, Clinical Applications and Public Health

Track 1- 1: Viruses and Genomics

Track 1- 2: Viral Drug Resistance and Genotyping

Track 1- 3: Retroviruses

Track 1- 4: Respiratory, Herpes Virus, Dengue Fever and Other Emerging Viruses

Track 1- 5: Antivirals and Intervention and Behavioral Intervention

Track 2: Novel Antivirals Drug Discovery

Track 2- 1: Upstream Platform Technologies for Antiviral Drug Discovery

Track 2- 2: Medicinal Chemistry and and Rational Drug Design of Antivirals

Track 2- 3: Novel Drug Delivery System for Antivirals

Track 2- 4: Antisense as Antivirals

Track 2- 5: DNA and RNA polymerase Inhibitors

Track 2- 6: Fusion Inhibitors

Track 2- 7: Interferons

Track 2- 8: Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

Track 2- 9: Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs/NtRTIs)

Track 2- 10: Protease and Integrase Inhibitors

Track 2- 11: Neuraminidase Inhibitors (NIs)

Track 3: Antivirals Biotherapeutics

Track 3- 1: New Biomarkers for Antiviral Drug Discovery

Track 3- 2: Antibodies for Antiviral Therapeutics

Track 3- 3: Novel Antiviral Vaccines

Track 3- 4: Antiviral Immunomodulators/Immunostimulants, Interferons and other Biopharmaceuticals

Track 4: Pipeline Update and Business Development

Track 4- 1: Antivirals on HIV

Track 4- 2: Antivirals on HCV and HBV

Track 4- 3: Antivirals on Herpes Viruses and HPV

Track 4- 4: Influenza/Avian Flu and Respiratory Antivirals

Training Course

Course 1: Cross Infection Control and Combination Therapy

Course 2: Molecular Diagnositcs for Virus Infection

To keep the moment going, we are calling for speakers, papers, sponsorships, co-organizers and exhibitors from international institutions and organizations.

For more information, please see: http://www.bitlifesciences.com/wsa2009

Contact info:

Chris Huang

Program Coordinator

Organizing Committee of WSA-2008, China

26 Gaoneng Street, Room 405,

Dalian High-tech Zone,

Dalian, LN 116025, China

Email: chrisbit-wsa.com

Tel: 0086-411-84799609*813

Fax: 0086-411-84799629